13. Which one of the following statements is NOT a correct feature of Escherichia coli RNA polymerase?
(1) Presence of the σ subunit along with α2ββ’ω core RNA polymerase is required for its promoter specific binding.
(2) Presence of the σ subunit along with α2ββ’ω core RNA polymerase is not necessary for the core RNA polymerase α2ββ’ω to bind to the DNA template.
(3) Mutations in β subunit in its rifampicin resistance defining region (RRDR) confer rifampicin resistance phenotype.
(4) Mutations in σ subunit in its rifampicin resistance defining region (RRDR) confer rifampicin resistance phenotype.
Correct Answer: (4)
“Mutations in σ subunit in its rifampicin resistance defining region (RRDR) confer rifampicin resistance phenotype.”
This statement is NOT correct, making it the right choice for the MCQ.
Detailed Explanation
Let’s analyze each statement:
(1) Presence of the σ subunit along with α₂ββ′ω core RNA polymerase is required for its promoter-specific binding.
-
True
-
The σ subunit is essential for the RNA polymerase to recognize and bind to specific promoter sequences.
-
Without σ, the core enzyme binds DNA non-specifically.
(2) Presence of the σ subunit along with α₂ββ′ω core RNA polymerase is not necessary for the core RNA polymerase to bind to the DNA template.
-
True
-
The core enzyme (α₂ββ′ω) can bind DNA, but not promoter-specifically.
-
Hence, σ is needed for specific initiation, but not for general DNA binding.
(3) Mutations in β subunit in its rifampicin resistance defining region (RRDR) confer rifampicin resistance phenotype.
-
True
-
Rifampicin, an antibiotic, targets the β subunit of RNA polymerase.
-
Mutations in the RRDR region of the β subunit (rpoB gene) lead to rifampicin resistance.
(4) Mutations in σ subunit in its rifampicin resistance defining region (RRDR) confer rifampicin resistance phenotype.
-
False / NOT correct
-
The σ subunit is NOT the target of rifampicin.
-
The drug binds near the RNA exit tunnel of the β subunit.
-
There is no RRDR region in the σ subunit.
Conclusion
Only statement (4) is incorrect, making it the correct answer for this question.



39 Comments
Rani Sharma
May 28, 2025Done sir ✨
Suman bhakar
May 28, 2025👍👍
Akshay mahawar
May 28, 2025Done 👍
Pallavi gautam
May 28, 2025Done ✅
Arushi
May 28, 2025👍
Parul
May 28, 2025Done sir
Beena Meena
May 28, 2025👍
Shalu Choudhary
May 28, 2025Done ✅✅
Vishakha pareek
May 29, 2025👍👍
Minu
May 29, 2025👍👍
Seeta choudhary
May 29, 2025Outstanding explanation 🤞💫
Bhanwar Jaat
May 29, 2025👍
Priyam choudhary
May 29, 2025✅👍
Prami Masih
May 31, 2025Done sir ji
Shreeji Charan
June 1, 2025👍
Riya
June 2, 2025Well Explained
Kirti Agarwal
October 26, 2025Statement 4 is incorrect
Sonal Nagar
November 2, 2025Option 4
Heena Mahlawat
November 3, 2025Option 4
Roopal Sharma
November 3, 2025Option 4 sigma does not have RRDR region
Pooja
November 3, 2025Option 4
Mutations in σ subunit in its rifampicin resistance defining region (RRDR) confer rifampicin resistance phenotype
anjani sharma
November 3, 2025The antibiotic Rifampicin inhibits bacterial RNA Polymerase by binding to the beta$ subunit (encoded by the rpoB gene) and physically blocking the path of the nascent RNA, thereby preventing elongation past a length of 2–3 nucleotides.
Divya rani
November 3, 20254th is incorrect because the sigma subunit is not the target of rifampicin, the drug binds at RNA exit channel of the beta subunit and there is no RRDR region in the sigma subunit.
Bhawna Choudhary
November 3, 2025Done sir 👍
Aartii sharma
November 3, 2025Option 4 sigma dose not have RRDR region
Dipti Sharma
November 3, 2025Sigma subunit is NOT the target of rifampicin , as rifampicin targets beta subunit of rna polymerase.
HIMANI FAUJDAR
November 3, 2025Ans Option 4 is not correct because sigma subunit is not target of rifampicin but rifampicin binds near the RNA exit tunnelof beta subunit.There is no RRDR region in sigma subunit.
Dharmpal Swami
November 3, 2025Option 4 sigma dose not have RRDR region
Sneha kumawat
November 3, 2025Rifampin resistance tab hoti h jab beta subunit kr pRDR ME MUTATION HO
Anjali sharma
November 3, 2025Option 4 is correct
Shivani
November 3, 2025Option 4. Is correct answer
Aartii sharma
November 4, 2025Option 4
Rishita
November 4, 2025Mutations in σ subunit in its rifampicin resistance defining region (RRDR) confer rifampicin resistance phenotype.”
Rishita
November 4, 2025Option 4
Manisha choudhary
November 5, 2025Option 4 in correct h
sigma factor RNA polymerase core enzyme ki specific binding k liye jaruri h
RNA polymerase k paas DNA binding domain hota h vo kahi p bhi DNA p jaakr bind k4 jata h vahi s tc start kr deta RNA polymerase core enzyme ko binding k liye sigma factor ki jarurat nhi h
Beta subunit of RNA polymerase ko rifampicin drug s block kr skte h
Beta subunit k paas rifampicin resistance defining region hota h
RRDR m mutation hone p rifampicin resistance ho jaayega
Deepika Sheoran
November 4, 2025Option 4
sakshivijay
November 6, 20254 is correct option
MOHIT AKHAND
November 10, 2025Done sir ✅
Neelam Sharma
November 13, 2025Mutations in σ subunit in its rifampicin resistance defining region (RRDR) confer rifampicin resistance phenotype.